Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BICTEGRAVIR vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BICTEGRAVIR vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS: Safety Overview

Metric BICTEGRAVIR BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
Total FAERS Reports 116 176
Deaths Reported 13 0
Death Rate 11.2% N/A
Hospitalizations 36 110
Average Patient Age 45.8 yrs 66.0 yrs
% Female Patients 26.4% 91.7%
Manufacturer Gilead Sciences, Inc. N/A
Route ORAL N/A